Related Experiment Video

Updated: Jun 27, 2025

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

11.0K

BIRC3-HSP90B1 Interaction Inhibits Non-Small Cell Lung Cancer Progression through the Extracellular Signal-Regulated

Feng Suo1, Yuan Wu1, Qiong Zhou1

  • 1Department of Cardiothoracic Surgery, Xuzhou Cancer Hospital, Xuzhou 221000, P.R China.

ACS Omega
|May 6, 2024
PubMed

Insights

BIRC3, an apoptosis inhibitor, is downregulated in nonsmall cell lung cancer (NSCLC), acting as a tumor suppressor. Its interaction with HSP90B1 inhibits cancer progression and improves patient prognosis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Nonsmall cell lung cancer (NSCLC) poses significant treatment challenges due to poor long-term prognosis.
  • Inhibitor of apoptosis (IAP) proteins, like BIRC3, are implicated in tumor regulation, but BIRC3's role in NSCLC is unclear.

Purpose of the Study:

  • To investigate the expression, prognostic value, and functional role of BIRC3 in NSCLC.
  • To elucidate the molecular mechanisms underlying BIRC3's regulation of NSCLC progression.

Main Methods:

  • Analysis of BIRC3 expression in NSCLC tissues using TCGA and GEO databases.
  • In vitro studies involving BIRC3 overexpression and knockdown in NSCLC cells.
  • In vivo validation using a nude mouse model.
  • Co-immunoprecipitation (Co-IP) assays to identify BIRC3-interacting proteins.

Main Results:

  • BIRC3 expression is significantly downregulated in NSCLC tissues.
  • Higher BIRC3 expression correlates with improved patient prognosis.
  • BIRC3 suppresses NSCLC cell proliferation, migration, and invasion.
  • BIRC3 interacts with HSP90B1, reducing its expression and inhibiting the ERK signaling pathway.

Conclusions:

  • BIRC3 functions as a tumor suppressor in NSCLC.
  • BIRC3 directly interacts with HSP90B1 to negatively regulate the ERK pathway, hindering tumor progression.
  • BIRC3 holds potential as a prognostic biomarker for NSCLC.

More Related Videos

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures07:48

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

11.3K
Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

9.1K

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.5K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K